Table 3 Clinical characteristics of ITP... | American Society of Hematology

Table 3

Clinical characteristics of ITP patient cohort: inhibition of monocyte cytokine assay

Inhibition of monocyte cytokine assay, patient no.	Sex	Age, y	Treatment	Platelet count, 10⁹/L
Platelet counts < 50 × 10⁹/L (patients 13, 33, and 35 were splenectomized)
Same as 13³	M	54	No treatment	5
Same as 7	F	29	On TPO agent	17
31	F	72	On TPO agent	29
32	M	19	On TPO agent	29
33	F	59	On TPO agent	17
34	M	20	On TPO agent	33
35	F	63	On TPO agent plus IVIg	33
Platelet counts > 50 × 10⁹/L (patients 19, 25, and 36 were splenectomized)
36	M	58	In remission	372
Same as 8	F	18	On TPO agent	68
Same as 19⁵	M	57	On TPO agent	133
Same as 25	M	46	On TPO agent	93

Inhibition of monocyte cytokine assay, patient no.	Sex	Age, y	Treatment	Platelet count, 10⁹/L
Platelet counts < 50 × 10⁹/L (patients 13, 33, and 35 were splenectomized)
Same as 13³	M	54	No treatment	5
Same as 7	F	29	On TPO agent	17
31	F	72	On TPO agent	29
32	M	19	On TPO agent	29
33	F	59	On TPO agent	17
34	M	20	On TPO agent	33
35	F	63	On TPO agent plus IVIg	33
Platelet counts > 50 × 10⁹/L (patients 19, 25, and 36 were splenectomized)
36	M	58	In remission	372
Same as 8	F	18	On TPO agent	68
Same as 19⁵	M	57	On TPO agent	133
Same as 25	M	46	On TPO agent	93